Missed bolus doses: devastating for metabolic control in CSII-treated adolescents with type 1 diabetes

被引:89
作者
Olinder, Anna Lindholm [1 ,2 ]
Kernell, Anna [1 ,3 ]
Smide, Bibbi [2 ]
机构
[1] Sachs Childrens Hosp, SE-11883 Stockholm, Sweden
[2] Uppsala Univ, Dept Med Sci, Uppsala, Sweden
[3] Karolinska Inst, Dept Clin Res & Educ, Stockholm, Sweden
关键词
adolescents; diabetes mellitus type 1; insulin infusion systems; SMBG; SUBCUTANEOUS INSULIN INFUSION; QUALITY-OF-LIFE; YOUNG ADOLESCENTS; GLYCEMIC CONTROL; CHILDREN; PREDICTORS;
D O I
10.1111/j.1399-5448.2008.00462.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Olinder AL, Kernell A, Smide B. Missed bolus doses: devastating for metabolic control in CSII-treated adolescents with type 1 diabetes.Pediatric Diabetes 2009: 10: 142-148. To investigate the management of continuous subcutaneous insulin infusion (CSII) in adolescents with type 1 diabetes including their administration of bolus doses and to study relationships between insulin omission and metabolic control, body mass index, daily frequency of self-monitoring of blood glucose (SMBG) and bolus doses, health-related quality of life (HRQOL), the burden of diabetes and treatment satisfaction. Ninety CSII-treated (>= 6 months) adolescents aged 12-18 yr, from four diabetes clinics in Sweden, participated in the study. The adolescents recorded their meal intake the previous day, which was compared with downloaded pump data, and the frequency of missed boluses was stated. Haemoglobin A1c (HbA1c) and diabetes-related data were recorded. HRQOL and treatment satisfaction were measured with questionnaires. Thirty-eight per cent of the adolescents had missed > 15% of the doses the previous day, those had higher HbA1c (7.8 +/- 1.0 vs. 7.0 +/- 1.2%, p = 0.001), took fewer daily boluses (3.8 +/- 1.7 vs. 5.3 +/- 1.7, p < 0.001) and SMBG (2.4 +/- 1.8 vs. 3.6 +/- 1.8, p = 0.003), were less satisfied with their treatment (4.8 vs. 5.3, scale 0-6, p = 0.029) and perceived the medical treatment more negatively (72.1 vs. 79.7, scale 0-100, p = 0.029). Multiple linear regression analysis showed that the variations in HbA1c could be explained by the frequency of bolus doses (p = 0.013) and SMBG per day (p < 0.0001) adjusted for duration and age (r(2) = 0.339, p < 0.0001). Insulin omission was common. Those who missed doses were less satisfied and perceived more impact with the treatment. The frequencies of daily boluses and SMBG were associated with metabolic control. Diabetes teams need strategies to guide adolescents on how to avoid insulin omission.
引用
收藏
页码:142 / 148
页数:7
相关论文
共 29 条
[1]  
Ahern Jo Ann H, 2002, Pediatr Diabetes, V3, P10
[2]   Parental involvement in diabetes management tasks: Relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus [J].
Anderson, B ;
Ho, J ;
Brackett, J ;
Finkelstein, D ;
Laffel, L .
JOURNAL OF PEDIATRICS, 1997, 130 (02) :257-265
[3]   The European DISABKIDS project: Development of seven condition-specific modules to measure health related quality of life in children and adolescents [J].
Baars R.M. ;
Atherton C.I. ;
Koopman H.M. ;
Bullinger M. ;
Power M. ;
Bullinger M. ;
Schmidt S. ;
Petersen C. ;
Koopman H. ;
Baars R. ;
Hoare P. ;
Power M. ;
Atherton C. ;
Simeoni M.C. ;
Tsanakas J. ;
Karagianni P. ;
Hatziagorou E. ;
Vidalis A. ;
Chaplin J.E. ;
Quittan M. ;
Schuhfried O. ;
Hachemian N. ;
Thyen U. ;
Müller-Godeffroy E. .
Health and Quality of Life Outcomes, 3 (1)
[4]   ISPAD Clinical Practice Consensus Guidelines 2006-2007 - Insulin treatment [J].
Bangstad, Hans-Jacob ;
Danne, Thomas ;
Deeb, Larry C. ;
Jarosz-Chobot, Przemyslawa ;
Urakami, Tatsuhiko ;
Hanas, Ragnar .
PEDIATRIC DIABETES, 2007, 8 (02) :88-102
[5]   Continuous subcutaneous insulin infusion - A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes [J].
Boland, EA ;
Grey, M ;
Oesterle, A ;
Fredrickson, L ;
Tamborlane, WV .
DIABETES CARE, 1999, 22 (11) :1779-1784
[6]   Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy [J].
Burdick, J ;
Chase, HP ;
Slover, RH ;
Knievel, K ;
Scrimgeour, L ;
Maniatis, AK ;
Klingensmith, GJ .
PEDIATRICS, 2004, 113 (03) :E221-E224
[7]   The use of insulin pumps with meal bolus alarms in children with type 1 diabetes to improve glycemic control [J].
Chase, HP ;
Horner, B ;
McFann, K ;
Yetzer, H ;
Gaston, J ;
Banion, C ;
Fiallo-Scharer, R ;
Slover, R ;
Klingensmith, G .
DIABETES CARE, 2006, 29 (05) :1012-1015
[8]   Current practice of insulin pump therapy in children and adolescents -: the Hannover recipe [J].
Danne, Thomas ;
von Schuetz, Wolfgang ;
Lange, Karin ;
Nestoris, Claudia ;
Datz, Nicolin ;
Kordonouri, Olga .
PEDIATRIC DIABETES, 2006, 7 :25-31
[9]  
*EUR DIS GROUP, 2006, DISABKIDS QUESTIONNA, P24
[10]   Predictors of control of diabetes: Monitoring may be the key [J].
Haller, MJ ;
Stalvey, MS ;
Silverstein, JH .
JOURNAL OF PEDIATRICS, 2004, 144 (05) :660-661